PRTG logo

Portage Biotech (PRTG) Current Assets

Annual Current Assets

$7.70 M
-$5.98 M-43.73%

March 31, 2024

Summary

Performance

1-Year Change

-43.73%

3-Year Change

+55.58%

5-Year Change

+17.46%

15-Year Change

-86.99%

PRTG Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

15.26%
PRTG annual total current assets is higher than 15.26% of companies in Healthcare sector

High & Low

All-time High

$59.14 M
PRTG annual total current assets is currently -86.99% below its historical high of $59.14 million

3-Year Low

$4.95 M
PRTG annual total current assets is currently +55.58% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2024
PRTG previous annual earnings announcement was published on Mar 31, 2024

Next Annual Earnings Report Date

Feb 28, 2025
PRTG next annual earnings announcement is scheduled for Feb 28, 2025

OtherPRTGbalance sheetmetrics:

Annual Total Assets

$7.78 M
PRTG annual total assets is $7.78 million

Annual Total Liabilities

$4.45 M
PRTG annual total liabilities is $4.45 million

Annual Current Liabilities

$2.88 M
PRTG annual total current liabilities is $2.88 million

Annual Total Long Term Liabilities

$1.57 M
PRTG annual total long term liabilities is $1.57 million

Quarterly Current Assets

$2.69 M
-$2.51 M-48.31%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-89.18%

5-Year Change

-38.28%

PRTG Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

5.96%
PRTG quarterly total current assets is higher than 5.96% of companies in Healthcare sector

High & Low

All-time High

$237.30 M
PRTG quarterly total current assets is currently -98.87% below its historical high of $237.30 million

3-Year Low

$2.69 M
PRTG quarterly total current assets is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PRTG previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PRTG next earnings announcement is scheduled for Feb 28, 2025

OtherPRTGbalance sheetmetrics:

Quarterly Total Assets

$2.71 M
PRTG quarterly total assets is $2.71 million

Quarterly Total Liabilities

$2.01 M
PRTG quarterly total liabilities is $2.01 million

Quarterly Current Liabilities

$873.00 K
PRTG quarterly total current liabilities is $873.00 thousand

Quarterly Long Term Liabilities

$1.14 M
PRTG quarterly total long term liabilities is $1.14 million

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

Annual Current Assets

$7.70 M
PRTG annual total current assets is $7.70 million

Annual Cash & Cash Equivalents

$5.03 M
PRTG annual cash & cash equivalents is $5.03 million

Annual Accounts Receivable

-
PRTG annual accounts receivable value is unknown

Annual Inventory

-
PRTG annual inventory value is unknown

PRTG Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-43.7%0.0%
3 y3 years+55.6%-89.2%
5 y5 years+17.5%-38.3%

PRTG Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-69.0%+55.6%-89.8%at low
5 y5-year-69.0%+102.8%-91.2%at low
alltimeall time-87.0%>+9999.0%-98.9%>+9999.0%

Portage Biotech Current Assets History

DateAnnualQuarterly
Sep 2024
-
$2.69 M(-48.3%)
Jun 2024
-
$5.20 M(-32.5%)
Mar 2024
$84.00 K(-99.9%)
$7.70 M(+2.4%)
Dec 2023
-
$7.52 M(+19.9%)
Sep 2023
-
$6.27 M(-42.5%)
Jun 2023
-
$10.89 M(-20.4%)
Mar 2023
$85.45 M(-49.7%)
$13.68 M(-11.9%)
Dec 2022
-
$15.53 M(-9.5%)
Sep 2022
-
$17.17 M(-25.7%)
Jun 2022
-
$23.11 M(-6.9%)
Mar 2022
$169.83 M(-0.0%)
$24.83 M(-5.5%)
Dec 2021
-
$26.27 M(-8.3%)
Sep 2021
-
$28.64 M(-6.4%)
Jun 2021
-
$30.61 M(+518.9%)
Mar 2021
$169.91 M(+0.3%)
$4.95 M(+17.8%)
Dec 2020
-
$4.20 M(-14.5%)
Sep 2020
-
$4.91 M(-44.9%)
Jun 2020
-
$8.91 M(+134.9%)
Mar 2020
$169.38 M(+1.3%)
$3.79 M(+6.9%)
Dec 2019
-
$3.55 M(-18.5%)
Sep 2019
-
$4.35 M(-23.7%)
Jun 2019
-
$5.70 M(-12.9%)
Mar 2019
$167.16 M(+6903.1%)
$6.55 M(+5.7%)
Dec 2018
-
$6.20 M(-14.4%)
Sep 2018
-
$7.24 M(-3.2%)
Jun 2018
-
$7.47 M(-1.9%)
Mar 2018
$2.39 M(+210.8%)
$7.62 M(-95.6%)
Dec 2017
-
$173.22 M(-27.0%)
Sep 2017
-
$237.30 M(+49.2%)
Jun 2017
-
$159.04 M(+168.9%)
Mar 2017
$768.00 K(-90.1%)
$59.14 M(>+9900.0%)
Dec 2016
-
$298.60 K(-42.4%)
Sep 2016
-
$518.80 K(-93.9%)
Jun 2016
-
$8.51 M(+73.9%)
Mar 2016
$7.74 M(+157.9%)
$4.89 M(+56.0%)
Dec 2015
-
$3.14 M(-21.6%)
Sep 2015
-
$4.00 M(-33.4%)
Jun 2015
-
$6.00 M(+245.8%)
Mar 2015
$3.00 M(-0.1%)
$1.74 M(-36.7%)
Dec 2014
-
$2.74 M(+98.8%)
Sep 2014
-
$1.38 M(-17.4%)
Jun 2014
-
$1.67 M(-26.1%)
Mar 2014
$3.00 M(>+9900.0%)
$2.26 M(-47.9%)
Dec 2013
-
$4.34 M(+29.9%)
Sep 2013
-
$3.34 M(-11.1%)
Jun 2013
-
$3.76 M(+9.8%)
Mar 2013
$5600.00
$3.43 M(-5.6%)
Dec 2012
-
$3.63 M(-9.3%)
Sep 2012
-
$4.00 M(-42.0%)
DateAnnualQuarterly
Jun 2012
-
$6.91 M(-8.0%)
Mar 2012
$6700.00(-99.9%)
$7.51 M(+26.1%)
Dec 2011
-
$5.95 M(+936.3%)
Sep 2011
-
$574.30 K(-61.6%)
Jun 2011
-
$1.49 M(-38.7%)
Mar 2011
$7.18 M(+10.5%)
$2.44 M(-24.6%)
Dec 2010
-
$3.23 M(+17.8%)
Sep 2010
-
$2.75 M(-2.4%)
Jun 2010
-
$2.81 M(-27.4%)
Mar 2010
$6.50 M(>+9900.0%)
$3.87 M(+60.4%)
Dec 2009
-
$2.42 M(+56.9%)
Sep 2009
-
$1.54 M(+2.7%)
Jun 2009
-
$1.50 M(+19.5%)
Mar 2009
$7500.00(+25.0%)
$1.25 M(-15.2%)
Dec 2008
-
$1.48 M(-51.1%)
Sep 2008
-
$3.02 M(-51.0%)
Jun 2008
-
$6.18 M(+21.5%)
Mar 2008
$6000.00(>+9900.0%)
$5.08 M(-12.2%)
Dec 2007
-
$5.79 M(-11.4%)
Sep 2007
-
$6.54 M(-0.2%)
Jun 2007
-
$6.55 M(+13.3%)
Mar 2007
$0.00(0.0%)
$5.78 M(+12.0%)
Dec 2006
-
$5.17 M(-4.8%)
Sep 2006
-
$5.43 M(-1.5%)
Jun 2006
-
$5.51 M(+17.9%)
Mar 2006
$0.00(-100.0%)
$4.68 M(+66.1%)
Dec 2005
-
$2.82 M(+16.5%)
Sep 2005
-
$2.42 M(-22.3%)
Jun 2005
-
$3.11 M(-22.6%)
Mar 2005
$179.00 K(-90.7%)
$4.02 M(+737.3%)
Dec 2004
-
$479.70 K(+35.3%)
Sep 2004
-
$354.50 K(+61.8%)
Jun 2004
-
$219.10 K(-48.3%)
Mar 2004
$1.93 M(>+9900.0%)
$423.40 K(+3399.2%)
Dec 2003
-
$12.10 K(-71.3%)
Sep 2003
-
$42.10 K(-90.6%)
Jun 2003
-
$448.30 K(+2199.0%)
Mar 2003
$0.00(-100.0%)
$19.50 K(-35.0%)
Dec 2002
-
$30.00 K(+361.5%)
Sep 2002
-
$6500.00(-60.1%)
Jun 2002
-
$16.30 K(-61.9%)
Mar 2002
$86.70 K(-41.4%)
$42.80 K(-27.2%)
Dec 2001
-
$58.80 K(-80.3%)
Sep 2001
-
$298.10 K(-21.3%)
Jun 2001
-
$378.60 K(-11.7%)
Mar 2001
$148.00 K(-74.4%)
$428.60 K(-31.5%)
Dec 2000
-
$626.00 K
Mar 2000
$577.90 K(+1187.1%)
-
Mar 1999
$44.90 K(+14.2%)
-
Mar 1998
$39.30 K
-

FAQ

  • What is Portage Biotech annual total current assets?
  • What is the all time high annual current assets for Portage Biotech?
  • What is Portage Biotech annual current assets year-on-year change?
  • What is Portage Biotech quarterly total current assets?
  • What is the all time high quarterly current assets for Portage Biotech?
  • What is Portage Biotech quarterly current assets year-on-year change?

What is Portage Biotech annual total current assets?

The current annual current assets of PRTG is $7.70 M

What is the all time high annual current assets for Portage Biotech?

Portage Biotech all-time high annual total current assets is $59.14 M

What is Portage Biotech annual current assets year-on-year change?

Over the past year, PRTG annual total current assets has changed by -$5.98 M (-43.73%)

What is Portage Biotech quarterly total current assets?

The current quarterly current assets of PRTG is $2.69 M

What is the all time high quarterly current assets for Portage Biotech?

Portage Biotech all-time high quarterly total current assets is $237.30 M

What is Portage Biotech quarterly current assets year-on-year change?

Over the past year, PRTG quarterly total current assets has changed by $0.00 (0.00%)